[Immunotherapy in non-small cell lung cancer patients: back to the future.]

Volume: 110, Issue: 12, Pages: 587 - 593
Published: Dec 1, 2019
Abstract
With the advent of immunotherapy, the life expectancy of patients with advanced non-small cell lung cancer (NSCLC) is dramatically improved. As described in the most recent clinical trials, the addition of immunotherapy to the available therapeutic strategies, restoring an efficient immune response against neoplasms and establishing an immunological memory, is able to improve both patient's survival and quality of life. This paved the way for...
Paper Details
Title
[Immunotherapy in non-small cell lung cancer patients: back to the future.]
Published Date
Dec 1, 2019
Volume
110
Issue
12
Pages
587 - 593
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.